Spots Global Cancer Trial Database for advanced gastric cancer
Every month we try and update this database with for advanced gastric cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel and Irinotecan in Advanced Gastric Cancer | NCT01136031 | Advanced Gastri... | Paclitaxel and ... | 18 Years - 70 Years | Seoul National University Hospital | |
| Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer | NCT00821990 | Advanced Gastri... | Chemotherapy Best supportive... | - 75 Years | Samsung Medical Center | |
| Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. | NCT06376773 | Advanced Gastri... Neoadjuvant The... Multi-omics Ana... | combination che... | 18 Years - 80 Years | Fujian Medical University | |
| Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | NCT01015339 | Advanced Gastri... | Paclitaxel capecitabine capecitabine cisplatin | 18 Years - | Peking University | |
| Bioinformation Therapy for Gastric Cancer | NCT03350477 | Advanced Gastri... | Cancer ablation Life informatio... | 20 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| A Study of the Efficacy and Safety of PerOx Quench on the Prevention of Oxaliplatin Treatment Induced Neuropathy | NCT02560740 | Colorectal Canc... Advanced Gastri... Neuropathy | PerOx Quench PerOx Quench Pl... | 18 Years - 80 Years | SMR Biotech Co., Ltd. | |
| A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer | NCT01946061 | Advanced Gastri... | S-1 plus oxalip... | 19 Years - 75 Years | Yonsei University | |
| A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor | NCT03393416 | Advanced Gastri... | MASCT-I PD1 antibody | 18 Years - 70 Years | HRYZ Biotech Co. | |
| Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer | NCT00669370 | Stomach Neoplas... | docetaxel and c... | 18 Years - | University of Turku | |
| Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer | NCT03137004 | Advanced Gastri... | Docetaxel S-1 | 18 Years - 75 Years | Fujian Cancer Hospital | |
| A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy | NCT01248403 | Advanced Gastri... Esophagogastric... | Paclitaxel RAD001 | 18 Years - | Krankenhaus Nordwest | |
| Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer | NCT03137004 | Advanced Gastri... | Docetaxel S-1 | 18 Years - 75 Years | Fujian Cancer Hospital | |
| Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer | NCT01084330 | Advanced Gastri... Gastro-esophage... | AUY922 Docetaxel Irinotecan | 18 Years - | Novartis | |
| Camrelizumab Combined With Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer | NCT04195828 | Advanced Gastri... | Camrelizumab Apatinib Mesyla... nab-paclitaxel S1 | 18 Years - 75 Years | Fujian Medical University | |
| RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX | NCT01049620 | Advanced Gastri... | RAD001, Capecit... | 18 Years - 70 Years | Asan Medical Center | |
| Feasibility Study of Intraperitoneal Paclitaxel | NCT01739894 | Gastric Cancer | IP Paclitaxel | 21 Years - 99 Years | National University Hospital, Singapore | |
| Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer | NCT06432075 | Advanced Gastri... | Neoantigen Reac... | 18 Years - 75 Years | First Affiliated Hospital of Wenzhou Medical University | |
| Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer | NCT03273920 | Gastric Cancer | Robotic distal ... Laparoscopic di... | 20 Years - 75 Years | Southwest Hospital, China | |
| Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy | NCT05649163 | HER2 Advanced Gastri... Advanced Gastro... Advanced Solid ... | Disitamab Vedot... | 18 Years - | Peking University | |
| Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins | NCT02348229 | Gastric Cancer | ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols conventional pa... conventional pa... conventional pa... conventional pa... conventional pa... conventional pa... | 18 Years - 75 Years | The First Hospital of Jilin University | |
| Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin | NCT00976768 | Advanced Gastri... | oxaliplatin, 5-... | 18 Years - | Asan Medical Center | |
| Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer | NCT00486954 | Neoplasms, Gast... | Lapatinib Paclitaxel | 20 Years - | GlaxoSmithKline | |
| A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer Patients | NCT05584592 | Advanced Gastri... | Intergrate earl... Conventional ch... | 19 Years - | Yonsei University | |
| Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer | NCT01525771 | Stage IV Gastri... | Docetaxel | 18 Years - | Asan Medical Center | |
| FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer | NCT01503372 | Advanced Gastri... | Pazopanib 5-FU, Oxaliplat... | 18 Years - | Charite University, Berlin, Germany | |
| A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer Patients | NCT05584592 | Advanced Gastri... | Intergrate earl... Conventional ch... | 19 Years - | Yonsei University | |
| A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination | NCT04797923 | Advanced Gastri... Peritoneal Carc... | 1. Treatment: I... 2. Response eva... | 19 Years - 75 Years | Gangnam Severance Hospital | |
| Maintenance Treatment With S-1 in Gastric Cancer Patients | NCT03701373 | Gastric Cancer ... Cancer of Stoma... | S-1 maintenance Observation | 18 Years - 80 Years | Sun Yat-sen University | |
| A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer | NCT01946061 | Advanced Gastri... | S-1 plus oxalip... | 19 Years - 75 Years | Yonsei University | |
| Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients | NCT01402401 | Advanced Gastri... | AUY922 Trastuzumab | 18 Years - | Novartis | |
| Feasibility Study of Intraperitoneal Paclitaxel | NCT01739894 | Gastric Cancer | IP Paclitaxel | 21 Years - 99 Years | National University Hospital, Singapore | |
| RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment | NCT00729482 | Stomach Neoplas... | RAD001 | 18 Years - 75 Years | Asan Medical Center | |
| Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer | NCT02072317 | Advanced Gastri... | taxel plus ralt... taxol | 18 Years - 75 Years | Fudan University | |
| Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis | NCT02071043 | Advanced Gastri... | Capecitabine Oxaliplatin | 18 Years - 80 Years | Shanghai Zhongshan Hospital | |
| The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant Chemotherapy | NCT02902575 | Stomach Neoplas... | Laparoscopic-as... | 18 Years - 75 Years | Fujian Medical University | |
| A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination | NCT04797923 | Advanced Gastri... Peritoneal Carc... | 1. Treatment: I... 2. Response eva... | 19 Years - 75 Years | Gangnam Severance Hospital | |
| Efficacy Study of TKcell in Advanced Gastric Cancer | NCT00854854 | Advanced Gastri... | TKCell | 19 Years - | Binex | |
| Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric Cancer | NCT02123407 | Advanced Gastri... | Carbon Nanopart... Gastrectomy wit... | 20 Years - 80 Years | Peking University | |
| Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP | NCT00565370 | Advanced Gastri... | Capecitabine, C... | 18 Years - 75 Years | Asan Medical Center | |
| A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | NCT01851941 | Advanced Gastri... | mFOLFOX6 (folin... | 18 Years - 75 Years | Seoul National University Hospital | |
| Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer | NCT00568529 | Gastric Cancer | Capecitabine an... | 18 Years - 70 Years | Fudan University | |
| Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy | NCT04808466 | Gastric Cancer Chemotherapy Ef... Surgery Metastasis Survival | Paclitaxel Lobaplatin | 18 Years - 75 Years | Wuhan Union Hospital, China | |
| Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer | NCT00842491 | Advanced Gastri... | endostar, cispl... capecitabine cisplatin | 18 Years - 75 Years | Peking University | |
| IMM2902, a HER2/SIRPα Bispecific mAb-Trap Antibody-receptor Fusion Protein, in Patients With HER2-expressing Advanced Solid Tumors | NCT05076591 | Advanced Solid ... Advanced Breast... Advanced Gastri... | IMM2902 | 18 Years - | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | |
| Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer | NCT06346093 | Advanced Gastri... | Fecal Microbiot... Placebo | 18 Years - | Changhai Hospital | |
| A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China | NCT01472250 | Advanced Gastri... | Clinical chemo-... | 18 Years - 85 Years | Peking University | |
| Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric Cancer | NCT00992199 | Advanced Gastri... | cisplatin, Fluo... | 18 Years - 70 Years | Fudan University | |
| Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis | NCT02071043 | Advanced Gastri... | Capecitabine Oxaliplatin | 18 Years - 80 Years | Shanghai Zhongshan Hospital | |
| Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer | NCT02142322 | Advanced Gastri... | MODIFIED FOLFOX... | 18 Years - | Seoul National University Hospital | |
| Long-term Oncologic Outcomes of Robotic Versus Laparoscopic Total Gastrectomy for Advanced Gastric Cancer | NCT05181306 | Gastric Cancer | Robotic-assiste... Laparoscopic-as... | 18 Years - 80 Years | Southwest Hospital, China | |
| Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy | NCT02451956 | Advanced Gastri... | AZD5363 paclitaxel | 20 Years - | Samsung Medical Center | |
| Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC | NCT04890392 | Advanced Gastri... Advanced Gastro... | PD-1 inhibitor(... | 18 Years - 75 Years | Wuhan Union Hospital, China | |
| Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not | NCT05871099 | Gastric Cancer | Hyperthermic In... | 18 Years - 80 Years | The Affiliated Hospital of Qingdao University | |
| Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients | NCT01402401 | Advanced Gastri... | AUY922 Trastuzumab | 18 Years - | Novartis | |
| Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer | NCT00842244 | Stomach Neoplas... Advanced Gastri... | axitinib capecitabine cisplatin | 18 Years - | Pfizer | |
| Comparison of Ability of pCLE and WLE for Diagnosis and Cancer Tissue Acquisition in Advanced Gastric Cancer After Chemotherapy Status | NCT03449966 | Advanced Gastri... Neoadjuvant Che... Palliative Chem... | Confocal group Control group | 20 Years - 80 Years | Yonsei University | |
| A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy | NCT01248403 | Advanced Gastri... Esophagogastric... | Paclitaxel RAD001 | 18 Years - | Krankenhaus Nordwest | |
| Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy | NCT05649163 | HER2 Advanced Gastri... Advanced Gastro... Advanced Solid ... | Disitamab Vedot... | 18 Years - | Peking University | |
| Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins | NCT02348229 | Gastric Cancer | ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols conventional pa... conventional pa... conventional pa... conventional pa... conventional pa... conventional pa... | 18 Years - 75 Years | The First Hospital of Jilin University | |
| Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer | NCT03286244 | Advanced Gastri... | CM082 plus pacl... | 18 Years - 70 Years | AnewPharma | |
| IMC001 for Clinical Research on Advanced Digestive System Malignancies | NCT05028933 | Advanced Hepato... Advanced Colore... Advanced Gastri... Advanced Pancre... | EPCAM CAR-T | 18 Years - 70 Years | Zhejiang University | |
| Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer | NCT04286711 | Advanced Gastri... | Albumin-paclita... | 18 Years - 70 Years | China Medical University, China | |
| Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer | NCT01206218 | Advanced Gastri... | FLOT Regimen FLO Regimen or ... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer | NCT06432075 | Advanced Gastri... | Neoantigen Reac... | 18 Years - 75 Years | First Affiliated Hospital of Wenzhou Medical University | |
| A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China | NCT01472250 | Advanced Gastri... | Clinical chemo-... | 18 Years - 85 Years | Peking University | |
| Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study") | NCT01779583 | Gastric Cancer | 18 Years - | Hospital Miguel Servet | ||
| Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer | NCT02142322 | Advanced Gastri... | MODIFIED FOLFOX... | 18 Years - | Seoul National University Hospital | |
| Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer | NCT00669370 | Stomach Neoplas... | docetaxel and c... | 18 Years - | University of Turku | |
| PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer | NCT01152853 | Advanced Gastri... HER2 | PF00299804 | 18 Years - | Seoul National University Hospital | |
| Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer | NCT00568529 | Gastric Cancer | Capecitabine an... | 18 Years - 70 Years | Fudan University | |
| Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins | NCT02348229 | Gastric Cancer | ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols ERAS protocols conventional pa... conventional pa... conventional pa... conventional pa... conventional pa... conventional pa... | 18 Years - 75 Years | The First Hospital of Jilin University | |
| Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer | NCT02305043 | Esophageal Neop... Stomach Neoplas... | non-interventio... | 18 Years - | University of Leipzig | |
| Laparoscopic Gastrectomy for Advanced Gastric Cancer | NCT01441336 | Advanced Gastri... Laparoscopic Ga... | Laparoscopic ga... | 20 Years - 80 Years | Seoul National University Bundang Hospital | |
| Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients | NCT01402401 | Advanced Gastri... | AUY922 Trastuzumab | 18 Years - | Novartis | |
| Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction | NCT01042782 | Advanced Gastri... Advanced Cancer... | RAD001 and Mito... | 18 Years - | Krankenhaus Nordwest | |
| The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer | NCT02038621 | Advanced Gastri... | Paclitaxel Oxaliplatin and... | 18 Years - | The Second People's Hospital of Sichuan | |
| Maintenance Treatment With S-1 in Gastric Cancer Patients | NCT03701373 | Gastric Cancer ... Cancer of Stoma... | S-1 maintenance Observation | 18 Years - 80 Years | Sun Yat-sen University | |
| Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer | NCT01525771 | Stage IV Gastri... | Docetaxel | 18 Years - | Asan Medical Center | |
| Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer | NCT06169410 | Advanced Gastri... | nab-paclitaxel,... nab-paclitaxel,... | 18 Years - 75 Years | Xijing Hospital | |
| S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer | NCT00343668 | Gastric Cancer | S-1, irinotecan | 18 Years - 70 Years | Korean Cancer Study Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
